Moreover, Camus et al. determined that recurrent exportin 1 gene mutations in tumor and cell-free circulating DNA can be used as a novel biomarker in patients with cHL using a highly sensitive digital PCR technique [93]. Here, XPO1 is linked to neoplasm.